Cyclerion Therapeutics (CYCN) Short Interest Ratio & Short Volume $2.90 -0.09 (-3.01%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cyclerion Therapeutics Short Interest DataCyclerion Therapeutics (CYCN) has a short interest of 84,900 shares, representing 4.33% of the float (the number of shares available for trading by the public). This marks a -28.72% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 69,058 shares to cover all short positions.Current Short Interest84,900 sharesPrevious Short Interest119,100 sharesChange Vs. Previous Month-28.72%Dollar Volume Sold Short$273,378.00Short Interest Ratio0.0 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares2,710,000 sharesFloat Size1,960,000 sharesShort Percent of Float4.33%Today's Trading Volume52,296 sharesAverage Trading Volume69,058 sharesToday's Volume Vs. Average76% Short Selling Cyclerion Therapeutics? Sign up to receive the latest short interest report for Cyclerion Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYCN Short Interest Over TimeCYCN Days to Cover Over TimeCYCN Percentage of Float Shorted Over Time Cyclerion Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202484,900 shares $273,378.00 -28.7%4.3%0 $3.22 12/15/2024119,100 shares $408,513.00 -84.1%6.1%0 $3.43 11/30/2024747,900 shares $1.65 million +13,498.2%38.2%0.3 $2.20 11/15/20245,500 shares $14,190.00 -61.8%0.3%0 $2.58 10/31/202414,400 shares $41,616.00 +20.0%0.7%1.1 $2.89 10/15/202412,000 shares $29,160.00 +11.1%0.6%1.9 $2.43 9/30/202410,800 shares $27,864.00 -17.6%0.5%1.8 $2.58 9/15/202413,100 shares $37,990.00 No Change0.6%2.3 $2.90 8/31/202413,100 shares $38,383.00 -3.0%0.6%2 $2.93 8/15/202413,500 shares $37,260.00 -18.2%0.7%2.2 $2.76 Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202416,500 shares $60,060.00 -4.6%0.8%2.8 $3.64 7/15/202417,300 shares $50,516.00 +10.9%0.8%3.6 $2.92 6/30/202415,600 shares $35,880.00 +7.6%0.8%3.9 $2.30 6/15/202414,500 shares $39,376.20 -18.5%0.7%4.5 $2.72 5/31/202417,800 shares $47,526.00 -4.3%0.9%8.9 $2.67 5/15/202418,600 shares $55,428.00 -4.1%0.9%8.1 $2.98 4/30/202419,400 shares $56,454.00 -4.0%1.0%7.2 $2.91 4/15/202420,200 shares $69,488.00 -8.6%1.0%7 $3.44 3/31/202422,100 shares $70,720.00 -6.0%1.2%7.4 $3.20 3/15/202423,500 shares $76,375.00 -4.9%1.3%7.8 $3.25 2/29/202424,700 shares $74,100.00 -7.8%1.3%4.2 $3.00 2/15/202426,800 shares $76,648.00 +9.8%1.6%3.6 $2.86 1/31/202424,400 shares $73,200.00 -5.8%1.4%3.1 $3.00 1/15/202425,900 shares $94,535.00 -15.1%1.5%3.4 $3.65 12/31/202330,500 shares $102,175.00 +1.0%1.7%3.5 $3.35 12/15/202330,200 shares $82,748.00 +87.6%1.7%3.5 $2.74 11/30/202316,100 shares $34,776.00 +21.1%0.9%2.2 $2.16 11/15/202313,300 shares $25,403.00 -14.2%0.7%2.1 $1.91 10/31/202315,500 shares $40,300.00 -13.9%0.8%2.2 $2.60 10/15/202318,000 shares $61,380.00 +13.2%0.9%2.1 $3.41 9/30/202315,900 shares $54,378.00 -14.5%0.8%1.8 $3.42 9/15/202318,600 shares $69,750.00 +5.7%1.0%1.8 $3.75 8/31/202317,600 shares $63,184.00 -31.8%0.8%1.6 $3.59 8/15/202325,800 shares $94,428.00 +23.4%1.2%2.1 $3.66 7/31/202320,900 shares $64,790.00 -37.8%1.0%0.7 $3.10 7/15/202333,600 shares $137,760.00 +20.0%1.6%1.1 $4.10 6/30/202328,000 shares $115,080.00 -22.7%1.2%1 $4.11 6/15/202336,200 shares $167,244.00 No Change1.7%1 $4.62 5/31/202336,200 shares $157,480.86 +168.2%1.9%1 $4.35 5/15/202313,500 shares $51,624.00 No Change0.8%0.4 $3.82$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 10/31/2022445,800 shares $245,190.00 +202.2%N/A2.1 $0.55 10/15/2022147,500 shares $61,404.25 -23.0%N/A0.7 $0.42 9/30/2022191,600 shares $164,776.00 -28.2%N/A1.3 $0.86 9/15/2022267,000 shares $245,613.30 +29.4%N/A1.7 $0.92 8/31/2022206,300 shares $173,292.00 +23.1%N/A0.8 $0.84 8/15/2022167,600 shares $149,164.00 -17.6%N/A0.6 $0.89 7/31/2022203,500 shares $195,360.00 -16.7%N/A0.8 $0.96 7/15/2022244,400 shares $221,426.40 -7.7%N/A1 $0.91 6/30/2022264,700 shares $145,267.36 +4.7%N/A1.1 $0.55 6/15/2022252,800 shares $122,987.20 +12.2%N/A1 $0.49 5/31/2022225,400 shares $140,334.04 -11.5%N/A1.7 $0.62 5/15/2022254,800 shares $143,962.00 -10.8%N/A2.2 $0.57 4/30/2022285,500 shares $210,270.75 -17.4%N/A2.4 $0.74 4/15/2022345,500 shares $345,500.00 -5.8%N/A2.6 $1.00 3/31/2022366,800 shares $407,148.00 -6.9%N/A2.6 $1.11 3/15/2022393,800 shares $393,800.00 -20.1%N/A2.2 $1.00 2/28/2022492,900 shares $517,545.00 -7.9%N/A2.3 $1.05 2/15/2022535,400 shares $599,648.00 -15.6%N/A1.7 $1.12 1/31/2022634,300 shares $837,276.00 +0.7%N/A1.9 $1.32 1/15/2022629,800 shares $875,422.00 +0.8%N/A1.8 $1.39 12/31/2021624,800 shares $1.07 million -59.4%N/A1.6 $1.72 12/15/20211,540,000 shares $2.70 million -6.1%N/A3.9 $1.75 11/30/20211,640,000 shares $3.58 million +11.6%N/A3.7 $2.18 11/15/20211,470,000 shares $3.95 million +1.4%N/A3.6 $2.69 10/29/20211,450,000 shares $3.71 million +17.9%N/A4 $2.56 10/15/20211,230,000 shares $3.31 million +6.0%N/A3.1 $2.69 9/30/20211,160,000 shares $3.56 million -2.5%N/A2.4 $3.07 9/15/20211,190,000 shares $3.50 million -1.7%N/A2 $2.94 8/31/20211,210,000 shares $4.14 million -6.2%N/A1.7 $3.42 8/13/20211,290,000 shares $4.09 million -7.2%N/A1 $3.17 7/30/20211,390,000 shares $4.04 million -12.6%N/A1 $2.91 7/15/20211,590,000 shares $5.26 million -14.5%4.7%1.1 $3.31 6/30/20211,860,000 shares $7.25 million -41.5%5.5%1.4 $3.90 6/15/20213,180,000 shares $11.99 million +105.2%11.6%2.5 $3.77 5/28/20211,550,000 shares $5.02 million -11.4%5.6%1.4 $3.24 5/14/20211,750,000 shares $4.92 million +71.6%N/A3.2 $2.81 4/30/20211,020,000 shares $2.34 million +42.1%N/A1.9 $2.29 4/15/2021717,900 shares $1.97 million -6.7%N/A1 $2.75 3/31/2021769,300 shares $2.07 million +22.9%N/A1.1 $2.69 3/15/2021626,100 shares $2.67 million +14.7%N/A1 $4.27 2/26/2021546,000 shares $2.09 million -20.7%N/A0.8 $3.82 2/12/2021688,800 shares $3.09 million +12.6%N/A1 $4.49 1/29/2021611,700 shares $1.90 million +12.4%N/A0.9 $3.11 1/15/2021544,200 shares $1.86 million -6.7%N/A1.5 $3.42 12/31/2020583,000 shares $1.80 million -1.6%N/A1 $3.08 12/15/2020592,700 shares $1.94 million -3.6%N/A1 $3.27 11/30/2020614,700 shares $2.00 million -18.0%N/A1 $3.26 11/15/2020749,200 shares $2.12 million -4.1%N/A1.3 $2.83 10/30/2020781,000 shares $1.80 million -20.4%N/A1.5 $2.31 10/15/2020980,700 shares $3.29 million +4.6%N/A2 $3.35$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 9/30/2020937,900 shares $5.70 million +10.6%N/A3.4 $6.08 9/15/2020847,800 shares $6.35 million -7.1%N/A3 $7.49 8/31/2020913,000 shares $6.23 million -1.0%N/A3.1 $6.82 8/14/2020922,200 shares $4.79 million +9.9%N/A3.2 $5.19 7/31/2020839,500 shares $3.21 million -7.2%N/A3.1 $3.82 7/15/2020904,600 shares $4.27 million -13.0%3.9%3.7 $4.72 6/30/20201,040,000 shares $6.15 million +26.3%4.5%4.6 $5.91 6/15/2020823,400 shares $3.80 million -16.9%3.6%3.6 $4.61 5/29/2020990,200 shares $4.00 million -15.4%4.3%4.1 $4.04 5/15/20201,170,000 shares $4.25 million -6.4%5.1%4.1 $3.63 4/30/20201,250,000 shares $4.84 million -3.9%5.4%3.5 $3.87 4/15/20201,300,000 shares $4.25 million -13.3%5.5%3.2 $3.27 3/31/20201,500,000 shares $5.42 million -28.9%6.3%2.7 $3.61 3/13/20202,110,700 shares $5.80 million +8.8%9.0%6.3 $2.75 2/28/20201,940,000 shares $6.09 million +19.8%8.3%2.6 $3.14 2/14/20201,620,000 shares $5.28 million +1.3%6.9%2.1 $3.26 1/31/20201,600,000 shares $7.04 million +17.7%6.1%1.9 $4.40 CYCN Short Interest - Frequently Asked Questions What is Cyclerion Therapeutics' current short interest? Short interest is the volume of Cyclerion Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 84,900 shares of CYCN short. 4.33% of Cyclerion Therapeutics' shares are currently sold short. Learn More on Cyclerion Therapeutics' current short interest. What is a good short interest percentage for Cyclerion Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.33% of Cyclerion Therapeutics' floating shares are currently sold short. Is Cyclerion Therapeutics' short interest increasing or decreasing? Cyclerion Therapeutics saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 84,900 shares, a decline of 28.7% from the previous total of 119,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cyclerion Therapeutics' float size? Cyclerion Therapeutics currently has issued a total of 2,710,000 shares. Some of Cyclerion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclerion Therapeutics currently has a public float of 1,960,000 shares. How does Cyclerion Therapeutics' short interest compare to its competitors? 4.33% of Cyclerion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cyclerion Therapeutics: OKYO Pharma Limited (0.88%), Omega Therapeutics, Inc. (26.59%), Sol-Gel Technologies Ltd. (3.05%), ProMIS Neurosciences, Inc. (0.98%), RenovoRx, Inc. (0.49%), Akari Therapeutics, Plc (1.19%), Incannex Healthcare Inc. (0.48%), Cognition Therapeutics, Inc. (5.14%), Lisata Therapeutics, Inc. (0.24%), MiNK Therapeutics, Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Cyclerion Therapeutics stock? Short selling CYCN is an investing strategy that aims to generate trading profit from Cyclerion Therapeutics as its price is falling. CYCN shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cyclerion Therapeutics? A short squeeze for Cyclerion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYCN, which in turn drives the price of the stock up even further. How often is Cyclerion Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYCN, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies OKYO Pharma Short Squeeze Omega Therapeutics Short Squeeze Sol-Gel Technologies Short Squeeze ProMIS Neurosciences Short Squeeze RenovoRx Short Squeeze Akari Therapeutics Short Squeeze Incannex Healthcare Short Squeeze Cognition Therapeutics Short Squeeze Lisata Therapeutics Short Squeeze MiNK Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYCN) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCN Stock Alerts